STREPTOCOCCUS PNEUMONIAE (PNEUMOCOCCUS) MAJOR DISEASES:
PNEUMONIA MENINGITIS BACTAEREMIA
LESS SERIOUS: SINUSITIS OTITIS MEDIA BRONCHITIS This high-risk group includes adults 65 years of age or older and children younger than 2 years of age.
People who have conditions that weaken the
immune system, like diabetes, heart disease, lung disease, and HIV/AIDS, or people who smoke cigarettes or have asthma are also at increased risk for getting pneumococcal disease. Rates of nasopharyngeal colonization vary by age, geography, and population studied. Risk factors for pneumococcal carriage include age younger than 2 years (especially infants), attendance at out-of-home child care, exposure to overcrowding and household smoking, winter season, and lack of breastfeeding (despite the fact that protective factors in human milk have yet to be identified). Among adults, those living in households with young children are more likely to be colonized with pneumococcus in their nasopharynx than adults without such exposure TRANSMISSION Respiratory droplets, direct oral contacts, indirectly through articles freshly soiled with respiratory discharges
Pneumococcal infections are more common
during the winter and in early spring when respiratory diseases are more common. MANAGEMENT Practice hygiene and cleanliness Wash your hands often. If soap and water aren’t available, clean hands with hand sanitizer (containing at least 60% alcohol). Don’t touch your eyes, nose, or mouth. If you need to touch your face, make sure your hands are clean. Cover your mouth and nose with a tissue or your sleeve (not your hands) when coughing or sneezing. Try to avoid close contact, such as kissing, hugging, or sharing eating utensils or cups, with people who are sick. Antibiotics can treat pneumococcal disease. However, many types of pneumococcal bacteria have become resistant to some of the antibiotics used to treat these infections 2 TYPES OF VACCINE • PNEUMOCOCCAL CONJUGATE VACCINE - PROTECTS AGAINST 13 TYPES OF PNEUMOCOCCAL BACTERIA. - DOCTORS GIVE THIS VACCINE TO CHILDREN AT 2, 4, 6, AND 12 THROUGH 15 MONTHS OLD - THE VACCINE’S PROTECTION LASTS AT LEAST 3 YEARS. PNEUMOCOCCAL POLYSACCHARIDE VACCINE - PROTECTS AGAINST 23 TYPES OF PNEUMOCOCCAL BACTERIA - FOR ALL ADULTS 65 YEARS OR OLDER AND FOR THOSE 2 YEARS OR OLDER AT INCREASED RISK FOR DISEASE. VACCINES THAT HELP PROTECT AGAINST PNEUMOCOCCAL DISEASE WORK WELL, BUT CANNOT PREVENT ALL CASES. STUDIES SHOW THAT AT LEAST 1 DOSE OF PNEUMOCOCCAL CONJUGATE VACCINE PROTECTS • At least 8 in 10 babies from serious infections called invasive pneumococcal disease • 75 in 100 adults 65 years or older against invasive pneumococcal disease • 45 in 100 adults 65 years or older against pneumococcal pneumonia
Studies* show that 1 dose of pneumococcal polysaccharide vaccine protects
• Between 50 to 85 in 100 healthy adults against invasive pneumococcal disease POSSIBLE RISKS OF PCV AND PPSV VACCINES
Kids may have redness, tenderness, or swelling
where the shot was given. A child also might have a fever after getting the shot. There is a very small chance of an allergic reaction with any vaccine.